Int J Heart Fail.
2024 Jul;6(3):127-128. 10.36628/ijhf.2024.0038.
Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Are Beta-Blockers Still Relevant?
- Affiliations
-
- 1Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- KMID: 2558336
- DOI: http://doi.org/10.36628/ijhf.2024.0038
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Beta Blockers in Contemporary Cardiology: Is It Better to Cast Them Out?
- Beta-Blockers in Heart Failure with Preserved Ejection Fraction: Could Their Use Be Vindicated as an Acceptable Option in the Future Treatment Guideline?
- Precision Cardiology: Phenotype-targeted Therapies for HFmrEF and HFpEF
- Differences in the Effects of Beta-Blockers Depending on Heart Rate at Discharge in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
- Optimal Management of Heart Failure with Preserve Ejection Fraction
